AssetMark Inc’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-106
| Closed | -$3.1K | – | 1729 |
|
|
2022
Q4 | $3.1K | Hold |
106
| – | – | ﹤0.01% | 1399 |
|
|
2022
Q3 | $3K | Hold |
106
| – | – | ﹤0.01% | 1369 |
|
|
2022
Q2 | $5K | Buy |
106
+60
| +130% | +$2.83K | ﹤0.01% | 1312 |
|
|
2022
Q1 | $2K | Sell |
46
-3
| -6% | -$130 | ﹤0.01% | 1453 |
|
|
2021
Q4 | $2K | Buy |
49
+1
| +2% | +$41 | ﹤0.01% | 1401 |
|
|
2021
Q3 | $3K | Hold |
48
| – | – | ﹤0.01% | 1244 |
|
|
2021
Q2 | $2K | Buy |
48
+17
| +55% | +$708 | ﹤0.01% | 1226 |
|
|
2021
Q1 | $1K | Buy |
31
+5
| +19% | +$161 | ﹤0.01% | 1313 |
|
|
2020
Q4 | $1K | Sell |
26
-20
| -43% | -$769 | ﹤0.01% | 1369 |
|
|
2020
Q3 | $2K | Sell |
46
-42
| -48% | -$1.83K | ﹤0.01% | 1170 |
|
|
2020
Q2 | $4K | Sell |
88
-2
| -2% | -$91 | ﹤0.01% | 994 |
|
|
2020
Q1 | $4K | Sell |
90
-5
| -5% | -$222 | ﹤0.01% | 1122 |
|
|
2019
Q4 | $6K | Buy |
95
+5
| +6% | +$316 | ﹤0.01% | 1088 |
|
|
2019
Q3 | $5K | Buy |
+90
| New | +$5K | ﹤0.01% | 1060 |
|
|
2018
Q1 | – | Sell |
-2
| Closed | – | – | 2068 |
|
|
2017
Q4 | $0 | Sell |
2
-52
| -96% | – | ﹤0.01% | 2170 |
|
|
2017
Q3 | $3K | Buy |
54
+34
| +170% | +$1.89K | ﹤0.01% | 1239 |
|
|
2017
Q2 | $2K | Buy |
+20
| New | +$2K | ﹤0.01% | 1252 |
|